Endogenously produced tnf-α contributes to the expression of cxcl10/ip-10 in ifn-l3-activated plasmacytoid dendritic cells

Journal of Leukocyte Biology

Volumn 99, Issue 1, 2016, Pages 107-119

  Finotti, Giulia ^a   Tamassia, Nicola ^a   Calzetti, Federica ^a   Fattovich, Giovanna ^a   Cassatella, Marco A ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Antiviral response; Innate immunity; Interferons; PDCs

Indexed keywords

ADALIMUMAB; CD123 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; ETANERCEPT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INFLIXIMAB; INTERFERON; INTERFERON LAMBDA3; INTERLEUKIN 3; L SELECTIN; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; GAMMA INTERFERON; MEMBRANE ANTIGEN;

ARTICLE; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DENDRITIC CELL; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM;

ANTIGENS, SURFACE; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CXCL10; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84953385900     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3VMA0415-144R     Document Type: Article

References (64)

1. Levy, D. E., Mariè, I. J., Durbin, J. E. (2011) Induction and function oftype I and III interferon in response to viral infection. Curr. Opin. Virol. 1,476–486
2. Egli, A., Santer, D. M., O’Shea, D., Tyrrell, D. L., Houghton, M. (2014) The impact of the interferon-lambda family on the innate and adaptiveimmune response to viral infections. Emerg Microbes Infect 3, e51
3. Donnelly, R. P., Kotenko, S. V. (2010) Interferon-lambda: a new additionto an old family. J. Interferon Cytokine Res. 30, 555–564
4. Li, M., Liu, X., Zhou, Y., Su, S. B. (2009) Interferon-ls: the modulators ofantivirus, antitumor, and immune responses. J. Leukoc. Biol. 86, 23–32
5. Zhang, L., Jilg, N., Shao, R.-X., Lin, W., Fusco, D. N., Zhao, H., Goto, K., Peng, L. F., Chen, W. C., Chung, R. T. (2011) IL28B inhibits hepatitis Cvirus replication through the JAK-STAT pathway. J. Hepatol. 55, 289–298
6. Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., Sulkowski, M., McHutchison, J. G., Goldstein, D. B. (2009) Genetic variation in IL28Bpredicts hepatitis C treatment-induced viral clearance. Nature 461,399–401
7. Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., Powell, E., Riordan, S., Sheridan, D., Smedile, A., Fragomeli, V., Müller, T., Bahlo, M., Stewart, G. J., Booth, D. R., George, J. (2009) IL28B is associated with response tochronic hepatitis C interferon-alpha and ribavirin therapy. Nat. Genet. 41,1100–1104
8. Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., Ito, Y., Mita, E., Tanaka, E., Mochida, S., Murawaki, Y., Honda, M., Sakai, A., Hiasa, Y., Nishiguchi, S., Koike, A., Sakaida, I., Imamura, M., Ito, K., Yano, K., Masaki, N., Sugauchi, F., Izumi, N., Tokunaga, K., Mizokami, M.(2009) Genome-wide association of IL28B with response to pegylatedinterferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet.41, 1105–1109
9. Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’Huigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., Goedert, J. J., Kirk, G. D., Donfield, S. M., Rosen, H. R., Tobler, L. H., Busch, M. P., McHutchison, J. G., Goldstein, D. B., Carrington, M. (2009) Genetic variation in IL28Band spontaneous clearance of hepatitis C virus. Nature 461, 798–801
10. MacMicking, J. D. (2012) Interferon-inducible effector mechanisms incell-autonomous immunity. Nat. Rev. Immunol. 12, 367–382
11. Schneider, W. M., Chevillotte, M. D., Rice, C. M. (2014) Interferonstimulatedgenes: a complex web of host defenses. Annu. Rev. Immunol.32, 513–545
12. Hermant, P., Michiels, T. (2014) Interferon-l in the context of viralinfections: production, response and therapeutic implications. J. InnateImmun. 6, 563–574
13. Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., Ostrander, C., Dong, D., Shin, J., Presnell, S., Fox, B., Haldeman, B., Cooper, E., Taft, D., Gilbert, T., Grant, F. J., Tackett, M., Krivan, W., McKnight, G., Clegg, C., Foster, D., Klucher, K. M. (2003) IL-28, IL-29and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63–68
14. Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., Donnelly, R. P.(2003) IFN-lambdas mediate antiviral protection through a distinct classII cytokine receptor complex. Nat. Immunol. 4, 69–77
15. Sommereyns, C., Paul, S., Staeheli, P., Michiels, T. (2008) IFN-lambda(IFN-l) is expressed in a tissue-dependent fashion and primarily acts onepithelial cells in vivo. PLoS Pathog. 4, e1000017
16. Megjugorac, N. J., Gallagher, G. E., Gallagher, G. (2009) Modulation ofhuman plasmacytoid DC function by IFN-l1 (IL-29). J. Leukoc. Biol. 86,1359–1363
17. Yin, Z., Dai, J., Deng, J., Sheikh, F., Natalia, M., Shih, T., Lewis-Antes, A., Amrute, S. B., Garrigues, U., Doyle, S., Donnelly, R. P., Kotenko, S. V., Fitzgerald-Bocarsly, P. (2012) Type III IFNs are produced by andstimulate human plasmacytoid dendritic cells. J. Immunol. 189,2735–2745
18. Zhang, S., Kodys, K., Li, K., Szabo, G. (2013) Human type 2 myeloiddendritic cells produce interferon-l and amplify interferon-a in responseto hepatitis C virus infection. Gastroenterology 144, 414–425.e7
19. O’Connor, K. S., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M. W., Weltman, M. D., Stewart, G. J., Liddle, C., George, J., Booth, D. R. (2014) IFNL3 mediates interactionbetween innate immune cells: Implications for hepatitis C viruspathogenesis. Innate Immun. 20, 598–605
20. Collin, M., McGovern, N., Haniffa, M. (2013) Human dendritic cellsubsets. Immunology 140, 22–30
21. O’Doherty, U., Peng, M., Gezelter, S., Swiggard, W. J., Betjes, M., Bhardwaj, N., Steinman, R. M. (1994) Human blood contains two subsetsof dendritic cells, one immunologically mature and the other immature. Immunology 82, 487–493
22. Liu, Y.-J. (2005) IPC: professional type 1 interferon-producing cellsand plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23,275–306
23. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., Liu, Y. J. (1999) The nature of the principaltype 1 interferon-producing cells in human blood. Science 284,1835–1837
24. Grouard, G., Rissoan, M. C., Filgueira, L., Durand, I., Banchereau, J., Liu, Y. J. (1997) The enigmatic plasmacytoid T cells develop into dendriticcells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185,1101–1111
25. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F., Liu, Y. J. (2001) Subsets of human dendritic cell precursorsexpress different Toll-like receptors and respond to different microbialantigens. J. Exp. Med. 194, 863–869
26. Megjugorac NJ, Young HA, Amrute SB, Olshalsky SL, Fitzgerald-Bocarsly P. (2004); Virally stimulated plasmacytoid dendritic cells producechemokines and induce migration of T and NK cells. J. Leukoc. Biol. 75,504–514
27. Sozzani, S., Vermi, W., Del Prete, A., Facchetti, F. (2010) Traffickingproperties of plasmacytoid dendritic cells in health and disease. TrendsImmunol. 31, 270–277
28. Zitvogel, L., Terme, M., Borg, C., Trinchieri, G. (2006) Dendritic cell-NKcell cross-talk: regulation and physiopathology. Curr. Top. Microbiol.Immunol. 298, 157–174
29. Ito, T., Amakawa, R., Inaba, M., Hori, T., Ota, M., Nakamura, K., Takebayashi, M., Miyaji, M., Yoshimura, T., Inaba, K., Fukuhara, S. (2004) Plasmacytoid dendritic cells regulate Th cell responses through OX40ligand and type I IFNs. J. Immunol. 172, 4253–4259
30. Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., Uzè, G. (2004) Viral infection andToll-like receptor agonists induce a differential expression of type I and linterferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34, 796–805
31. Tamassia, N., Le Moigne, V., Rossato, M., Donini, M., McCartney, S., Calzetti, F., Colonna, M., Bazzoni, F., Cassatella, M. A. (2008) Activationof an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J. Immunol. 181, 6563–6573
32. Vermi, W., Micheletti, A., Lonardi, S., Costantini, C., Calzetti, F., Nascimbeni, R., Bugatti, M., Codazzi, M., Pinter, P. C., Schäkel, K., Tamassia, N., Cassatella, M. A. (2014) slanDCs selectively accumulate incarcinoma-draining lymph nodes and marginate metastatic cells. Nat.Commun. 5, 3029
33. Crepaldi, L., Gasperini, S., Lapinet, J. A., Calzetti, F., Pinardi, C., Liu, Y., Zurawski, S., de Waal Malefyt, R., Moore, K. W., Cassatella, M. A. (2001) Up-regulation of IL-10R1 expression is required to render humanneutrophils fully responsive to IL-10. J. Immunol. 167, 2312–2322
34. Ghirelli, C., Zollinger, R., Soumelis, V. (2010) Systematic cytokinereceptor profiling reveals GM-CSF as a novel TLR-independent activatorof human plasmacytoid predendritic cells. Blood 115, 5037–5040
35. Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K., Fukuhara, S.(2001) Differential regulation of human blood dendritic cell subsets byIFNs. J. Immunol. 166, 2961–2969
36. Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., Hartmann, G.(2001) Toll-like receptor expression reveals CpG DNA as a uniquemicrobial stimulus for plasmacytoid dendritic cells which synergizes withCD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31,3026–3037
37. Kohrgruber, N., Halanek, N., Gröger, M., Winter, D., Rappersberger, K., Schmitt-Egenolf, M., Stingl, G., Maurer, D. (1999) Survival, maturation,and function of CD11c2 and CD11c+ peripheral blood dendritic cells aredifferentially regulated by cytokines. J. Immunol. 163, 3250–3259
38. Lande, R., Gilliet, M. (2010) Plasmacytoid dendritic cells: key players inthe initiation and regulation of immune responses. Ann. N. Y. Acad. Sci.1183, 89–103
39. Blackwell, S. E., Krieg, A. M. (2003) CpG-A-induced monocyte IFNg-inducible protein-10 production is regulated by plasmacytoid dendriticcell-derived IFN-a. J. Immunol. 170, 4061–4068
40. Decalf, J., Fernandes, S., Longman, R., Ahloulay, M., Audat, F., Lefrerre, F., Rice, C. M., Pol, S., Albert, M. L. (2007) Plasmacytoid dendritic cellsinitiate a complex chemokine and cytokine network and are a viable drugtarget in chronic HCV patients. J. Exp. Med. 204, 2423–2437
41. Tamassia, N., Le Moigne, V., Calzetti, F., Donini, M., Gasperini, S., Ear, T., Cloutier, A., Martinez, F. O., Fabbri, M., Locati, M., Mantovani, A., McDonald, P. P., Cassatella, M. A. (2007) The MyD88-independentpathway is not mobilized in human neutrophils stimulated via TLR4.J. Immunol. 178, 7344–7356
42. Cassatella, M. A., Mosna, F., Micheletti, A., Lisi, V., Tamassia, N., Cont, C., Calzetti, F., Pelletier, M., Pizzolo, G., Krampera, M. (2011) Toll-likereceptor-3-activated human mesenchymal stromal cells significantlyprolong the survival and function of neutrophils. Stem Cells 29,1001–1011
43. Ohmori, Y., Hamilton, T. A. (1995) The interferon-stimulated responseelement and a kappa B site mediate synergistic induction of murine IP-10gene transcription by IFN-gamma and TNF-alpha. J. Immunol. 154,5235–5244
44. Tamassia, N., Calzetti, F., Ear, T., Cloutier, A., Gasperini, S., Bazzoni, F., McDonald, P. P., Cassatella, M. A. (2007) Molecular mechanismsunderlying the synergistic induction of CXCL10 by LPS and IFN-gammain human neutrophils. Eur. J. Immunol. 37, 2627–2634
45. Clarke, D. L., Clifford, R. L., Jindarat, S., Proud, D., Pang, L., Belvisi, M., Knox, A. J. (2010) TNFa and IFNg synergistically enhance transcriptionalactivation of CXCL10 in human airway smooth muscle cells via STAT-1,NF-kB, and the transcriptional coactivator CREB-binding protein. J. Biol.Chem. 285, 29101–29110
46. Gibson, S. J., Lindh, J. M., Riter, T. R., Gleason, R. M., Rogers, L. M., Fuller, A. E., Oesterich, J. L., Gorden, K. B., Qiu, X., McKane, S. W., Noelle, R. J., Miller, R. L., Kedl, R. M., Fitzgerald-Bocarsly, P., Tomai, M. A., Vasilakos, J. P. (2002) Plasmacytoid dendritic cells producecytokines and mature in response to the TLR7 agonists, imiquimod andresiquimod. Cell. Immunol. 218, 74–86
47. Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., Vasilakos, J. P. (2005) Synthetic TLRagonists reveal functional differences between human TLR7 and TLR8.J. Immunol. 174, 1259–1268
48. Reed, G. F., Lynn, F., Meade, B. D. (2002) Use of coefficient of variationin assessing variability of quantitative assays. Clin. Diagn. Lab. Immunol. 9,1235–1239
49. Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., Tak, P. P. (2008) Tumor necrosis factor antagonist mechanisms of action:a comprehensive review. Pharmacol. Ther. 117, 244–279
50. Heim, M. H. (2013) Innate immunity and HCV. J. Hepatol. 58, 564–574
51. O’Connor, K. S., George, J., Booth, D., Ahlenstiel, G. (2014) Dendriticcells in hepatitis C virus infection: key players in the IFNL3-genotyperesponse. World J. Gastroenterol. 20, 17830–17838
52. Osawa, Y., Iho, S., Takauji, R., Takatsuka, H., Yamamoto, S., Takahashi, T., Horiguchi, S., Urasaki, Y., Matsuki, T., Fujieda, S. (2006) Collaborativeaction of NF-kB and p38 MAPK is involved in CpG DNA-induced IFN-aand chemokine production in human plasmacytoid dendritic cells. J. Immunol. 177, 4841–4852
53. Pekarek, V., Srinivas, S., Eskdale, J., Gallagher, G. (2007) Interferonlambda-1 (IFN-l1/IL-29) induces ELR2 CXC chemokine mRNA inhuman peripheral blood mononuclear cells, in an IFN-g-independentmanner. Genes Immun. 8, 177–180
54. Akahoshi, M., Ishihara, M., Remus, N., Uno, K., Miyake, K., Hirota, T., Nakashima, K., Matsuda, A., Kanda, M., Enomoto, T., Ohno, S., Nakashima, H., Casanova, J. L., Hopkin, J. M., Tamari, M., Mao, X. Q., Shirakawa, T. (2004) Association between IFNA genotype and the risk ofsarcoidosis. Hum. Genet. 114, 503–509
55. Deng, G., Zhou, G., Zhang, R., Zhai, Y., Zhao, W., Yan, Z., Deng, C., Yuan, X., Xu, B., Dong, X., Zhang, X., Zhang, X., Yao, Z., Shen, Y., Qiang, B., Wang, Y., He, F. (2008) Regulatory polymorphisms in the promoter ofCXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 134, 716–726
56. Tang, N. L. S., Fan, H. P. Y., Chang, K. C., Ching, J. K. L., Kong, K. P. S., Yew, W. W., Kam, K. M., Leung, C. C., Tam, C. M., Blackwell, J., Chan, C. Y. (2009) Genetic association between a chemokine gene CXCL-10(IP-10, interferon gamma inducible protein 10) and susceptibility totuberculosis. Clin. Chim. Acta 406, 98–102
57. Wilson, N., Driss, A., Solomon, W., Dickinson-Copeland, C., Salifu, H., Jain, V., Singh, N., Stiles, J. (2013) CXCL10 gene promoterpolymorphism -1447A.G correlates with plasma CXCL10 levels and isassociated with male susceptibility to cerebral malaria. PLoS One 8,e81329
58. Chinnaswamy, S. (2014) Genetic variants at the IFNL3 locus and theirassociation with hepatitis C virus infections reveal novel insights into hostvirusinteractions. J. Interferon Cytokine Res. 34, 479–497
59. Krug, A., Uppaluri, R., Facchetti, F., Dorner, B. G., Sheehan, K. C. F., Schreiber, R. D., Cella, M., Colonna, M. (2002) IFN-producing cellsrespond to CXCR3 ligands in the presence of CXCL12 and secreteinflammatory chemokines upon activation. J. Immunol. 169,6079–6083
60. Horiuchi, T., Mitoma, H., Harashima, S., Tsukamoto, H., Shimoda, T.(2010) Transmembrane TNF-a: structure, function and interaction withanti-TNF agents. Rheumatology (Oxford) 49, 1215–1228
61. Zimmermann, M., Aguilera, F. B., Castellucci, M., Rossato, M., Costa, S., Lunardi, C., Ostuni, R., Girolomoni, G., Natoli, G., Bazzoni, F., Tamassia, N., Cassatella, M. A. (2015) Chromatin remodelling and autocrine TNFaare required for optimal interleukin-6 expression in activated humanneutrophils. Nat. Commun. 6, 6061
62. Nattermann, J., Zimmermann, H., Iwan, A., von Lilienfeld-Toal, M., Leifeld, L., Nischalke, H. D., Langhans, B., Sauerbruch, T., Spengler, U.(2006) Hepatitis C virus E2 and CD81 interaction may be associated withaltered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44,945–954
63. Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Uĝel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., Klucher, K. M., Doyle, S. E., Neurath, M. F., Finotto, S., Andreakos, E. (2011) IL-28A(IFN-l2) modulates lung DC function to promote Th1 immune skewingand suppress allergic airway disease. EMBO Mol. Med. 3, 348–361
64. Egli, A., Santer, D. M., O’Shea, D., Barakat, K., Syedbasha, M., Vollmer, M., Baluch, A., Bhat, R., Groenendyk, J., Joyce, M. A., Lisboa, L. F., Thomas, B. S., Battegay, M., Khanna, N., Mueller, T., Tyrrell, D. L., Houghton, M., Humar, A., Kumar, D. (2014) IL-28B is a key regulator ofB- and T-cell vaccine responses against influenza. PLoS Pathog. 10,e1004556.